More abundant Tregs were found in the center of ER-positive and in the peritumoral area of ER−/HER2+ cancers, while a lower number of cells infiltrated the intratumoral site of ER−/HER2+ tumors in Tsang et al. research [20]. This evidence concerns the gene ERBB2 and cancer.